Cancer Research The Future of Cancer Research: Science and Patient Impact  AACR Conference on Molecular Diagnostics - 2008
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 53, 2212-2216, May 15, 1993]
© 1993 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tishler, R. B.
Right arrow Articles by Price, B. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tishler, R. B.
Right arrow Articles by Price, B. D.

Increases in Sequence Specific DNA Binding by p53 following Treatment with Chemotherapeutic and DNA Damaging Agents1

Roy B. Tishler2, Stuart K. Calderwood, C. Norman Coleman and Brendan D. Price

Stress Protein Group, Joint Center for Radiation Therapy, Boston, Massachusetts 02115

We have investigated the effect of chemotherapeutic and DNA damaging agents on binding of the tumor suppressor phosphoprotein p53 to its consensus DNA sequence. Activation of p53-DNA binding was seen for treatment with radiation, hydrogen peroxide, actinomycin D, Adriamycin, etoposide, camptothecin, 5-fluorouracil, mitomycin C, and cisplatin. These results showed that DNA strand breaks were sufficient to lead to increased levels of p53. The protein synthesis inhibitor cycloheximide blocks the increase in p53 following DNA damage. The increase in p53 activation in camptothecin treated cells may result, at least in part, from an increased half-life of the protein and consequent increases in intracellular protein concentration.

1 Supported by NIH Grants R29CA-44940 and ROI 47407. R. B. T. was supported by an ASTRO Research Fellowship from the American Society for Therapeutic Radiology and Oncology.

2 To whom requests for reprints should be addressed, at Joint Center for Radiation Therapy, 50 Binney Street, Boston, MA 02115.

Received 2/19/93. Accepted 4/ 1/93.




This article has been cited by other articles:


Home page
Cancer Res.Home page
S. Bottger, E. Jerszyk, B. Low, and C. Walker
Genotoxic Stress-Induced Expression of p53 and Apoptosis in Leukemic Clam Hemocytes with Cytoplasmically Sequestered p53
Cancer Res., February 1, 2008; 68(3): 777 - 782.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
Y.-S. Lee, J. Wan, B.-J. Kim, M.-A. Bae, and B. J. Song
Ubiquitin-Dependent Degradation of p53 Protein Despite Phosphorylation at Its N Terminus by Acetaminophen
J. Pharmacol. Exp. Ther., April 1, 2006; 317(1): 202 - 208.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Rivera and S. A. Maxwell
The p53-induced Gene-6 (Proline Oxidase) Mediates Apoptosis through a Calcineurin-dependent Pathway
J. Biol. Chem., August 12, 2005; 280(32): 29346 - 29354.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. K. Ghosh, S. Bhattacharyya, and J. Varga
The Tumor Suppressor p53 Abrogates Smad-dependent Collagen Gene Induction in Mesenchymal Cells
J. Biol. Chem., November 12, 2004; 279(46): 47455 - 47463.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. Chavez-Reyes, J. M. Parant, L. L. Amelse, R. M. de Oca Luna, S. J. Korsmeyer, and G. Lozano
Switching Mechanisms of Cell Death in mdm2- and mdm4-null Mice by Deletion of p53 Downstream Targets
Cancer Res., December 15, 2003; 63(24): 8664 - 8669.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. L. Bronder and R. G. Moran
A Defect in the p53 Response Pathway Induced by de Novo Purine Synthesis Inhibition
J. Biol. Chem., December 5, 2003; 278(49): 48861 - 48871.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
B. Freie, X. Li, S. L. M. Ciccone, K. Nawa, S. Cooper, C. Vogelweid, L. Schantz, L. S. Haneline, A. Orazi, H. E. Broxmeyer, et al.
Fanconi anemia type C and p53 cooperate in apoptosis and tumorigenesis
Blood, December 1, 2003; 102(12): 4146 - 4152.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
A. G. Casson, S. C. Evans, A. Gillis, G. A. Porter, P. Veugelers, S. J. Darnton, D. L. Guernsey, and P. Hainaut
Clinical implications of p53 tumor suppressor gene mutation and protein expression in esophageal adenocarcinomas: Results of a ten-year prospective study
J. Thorac. Cardiovasc. Surg., May 1, 2003; 125(5): 1121 - 1131.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. M. Keller and H. Lu
p53 Serine 392 Phosphorylation Increases after UV through Induction of the Assembly of the CK2{middle dot}hSPT16{middle dot}SSRP1 Complex
J. Biol. Chem., December 13, 2002; 277(51): 50206 - 50213.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
G. Laurent and J.-P. Jaffrezou
Signaling pathways activated by daunorubicin
Blood, August 15, 2001; 98(4): 913 - 924.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
H. Offer, I. Zurer, G. Banfalvi, M. Reha’k, A. Falcovitz, M. Milyavsky, N. Goldfinger, and V. Rotter
p53 Modulates Base Excision Repair Activity in a Cell Cycle-specific Manner after Genotoxic Stress
Cancer Res., January 1, 2001; 61(1): 88 - 96.
[Abstract] [Full Text]


Home page
Cancer Res.Home page
C. J. Kemp, S. Sun, and K. E. Gurley
p53 Induction and Apoptosis in Response to Radio- and Chemotherapy in Vivo Is Tumor-Type-dependent
Cancer Res., January 1, 2001; 61(1): 327 - 332.
[Abstract] [Full Text]


Home page
Cancer Res.Home page
G. Xiao, A. Chicas, M. Olivier, Y. Taya, S. Tyagi, F. R. Kramer, and J. Bargonetti
A DNA Damage Signal Is Required for p53 to Activate gadd45
Cancer Res., March 1, 2000; 60(6): 1711 - 1719.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
F. Moretti, S. Nanni, A. Farsetti, M. Narducci, M. Crescenzi, S. Giuliacci, A. Sacchi, and A. Pontecorvi
Effects of Exogenous p53 Transduction in Thyroid Tumor Cells with Different p53 Status
J. Clin. Endocrinol. Metab., January 1, 2000; 85(1): 302 - 308.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
E. C. Thornborrow and J. J. Manfredi
One Mechanism for Cell Type-specific Regulation of the bax Promoter by the Tumor Suppressor p53 Is Dictated by the p53 Response Element
J. Biol. Chem., November 19, 1999; 274(47): 33747 - 33756.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
U. P. Kelavkar and K. F. Badr
Effects of mutant p53 expression on human 15-lipoxygenase-promoter activity and murine 12/15-lipoxygenase gene expression: Evidence that 15-lipoxygenase is a mutator gene
PNAS, April 13, 1999; 96(8): 4378 - 4383.
[Abstract] [Full Text] [PDF]


Home page
The OncologistHome page
M. R. Posner, P. G. Johnston, R. B. Tishler, J. Andersen, M. Fiorentino, P. M. Busse, L. A. Cavacini, A. D. Colevas, J. Clark, and C. M. Norris
The Prognostic Value of Thymidylate Synthase and p53 Expression in Patients Treated with Induction Chemotherapy for Squamous Cell Carcinoma of the Head and Neck
Oncologist, December 1, 1998; 3(6): 424 - 431.
[Abstract] [Full Text]


Home page
Am. J. Pathol.Home page
J. W. Wilson, D. M. Pritchard, J. A. Hickman, and C. S. Potten
Radiation-Induced p53 and p21WAF-1/CIP1 Expression in the Murine Intestinal Epithelium : Apoptosis and Cell Cycle Arrest
Am. J. Pathol., September 1, 1998; 153(3): 899 - 909.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
J. S. Lanni and T. Jacks
Characterization of the p53-Dependent Postmitotic Checkpoint following Spindle Disruption
Mol. Cell. Biol., February 1, 1998; 18(2): 1055 - 1064.
[Abstract] [Full Text]


Home page
Mol. Cell. Biol.Home page
O. B. Chernova, M. V. Chernov, Y. Ishizaka, M. L. Agarwal, and G. R. Stark
MYC Abrogates p53-Mediated Cell Cycle Arrest in N-(Phosphonacetyl)-L-Aspartate-Treated Cells, Permitting CAD Gene Amplification
Mol. Cell. Biol., January 1, 1998; 18(1): 536 - 545.
[Abstract] [Full Text]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. S. Eller, T. Maeda, C. Magnoni, D. Atwal, and B. A. Gilchrest
Enhancement of DNA repair in human skin cells by thymidine dinucleotides: Evidence for a p53-mediated mammalian SOS response
PNAS, November 11, 1997; 94(23): 12627 - 12632.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
G. Teoh, M. Urashima, A. Ogata, D. Chauhan, J. A. DeCaprio, S. P. Treon, R. L. Schlossman, and K. C. Anderson
MDM2 Protein Overexpression Promotes Proliferation and Survival of Multiple Myeloma Cells
Blood, September 1, 1997; 90(5): 1982 - 1992.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
Y. Wu, H. Huang, Z. Miner, and M. Kulesz-Martin
Activities and response to DNA damage of latent and active sequence-specific DNA binding forms of mouse p53
PNAS, August 19, 1997; 94(17): 8982 - 8987.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. T. Osborn and T. C. Chambers
Role of the Stress-activated/c-Jun NH2-terminal Protein Kinase Pathway in the Cellular Response to Adriamycin and Other Chemotherapeutic Drugs
J. Biol. Chem., November 29, 1996; 271(48): 30950 - 30955.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
A Di Leonardo, S P Linke, K Clarkin, and G M Wahl
DNA damage triggers a prolonged p53-dependent G1 arrest and long-term induction of Cip1 in normal human fibroblasts.
Genes & Dev., November 1, 1994; 8(21): 2540 - 2551.
[Abstract] [PDF]


Home page
J. Cell Sci.Home page
R Dover, Y Jayaram, K Patel, and R Chinery
p53 expression in cultured cells following radioisotope labelling
J. Cell Sci., January 5, 1994; 107(5): 1181 - 1184.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1993 by the American Association for Cancer Research.